Clarient Diagnostic Services, a GE Healthcare company, has entered into an agreement to license genomic biomarker for lung cancer from Insight Genetics. AS per the agreement, Clarient intends to develop and assess the performance ...
Tags: Lung Cancer, cooperation, medical technology
University of California San Francisco (UCSF) Medical Center has purchased BSD Medical's BSD-2000 hyperthermia system. UCSF Medical Center is involved in providing advanced technology and care to patients suffering with cancer. By ...
Tags: UCSF, BSD Medical, BSD-2000 hyperthermia system, cancer
A Dell business development manager will be selling his own art during a self-hosted exhibit, with the hope of raising a six figure digit for charity. Hany Maurice, Business Development Manager, Software and Peripherals, ME, will be ...
Tags: Art, Cancer, Charity, Dell, Gallery, highlightedpost, Middle East
University of California, San Francisco's (UCSF) Helen Diller Family Comprehensive Cancer Center has installed Accuray's TomoTherapy system to provide treatment options for cancer patients. The TomoTherapy system, designed for integrated, ...
Tags: Accuray Tomotherapy System, Accuray's TomoTherapy system
Affibody has entered into a collaboration agreement with GE Healthcare to develop a Her2-targeted PET imaging agent for detecting breast and gastric cancer. The clinical trials for the Her2-targeted PET imaging agent is scheduled to ...
Tags: company cooperation, clinical research, breast cancer, gastric cancer
Astellas Pharma US is seeking FDA approval for Tarceva tablets to treat non-small cell lung cancer patients (NSCLC) with tumors containing epidermal growth factor receptor (EGFR) that triggers mutations. The company submitted a ...
Mauna Kea Technologies has obtained CE mark for its UroFlex confocal miniprobe, designed for use in urological applications. The optical biopsy probe, the first urological probe in the Cellvizio portfolio, provides physicians with an ...
Tags: Mauna Kea Technologies, CE mark, TURBT
Galena Biopharma and Leica Biosystems have joined forces to develop a companion diagnostic for Galena's NeuVax(nelipepimut-S or E75),a breast cancer therapeutic. As part of the partnership,Leica's Bond Oracle HER2 IHC System companion ...
Multinational biopharmaceutical company Celgene has received US Food and Drug Administration (FDA) approval for Abraxane, which is aimed to treat locally advanced or metastatic non-small cell lung cancer in combination with carboplatin in ...
Tags: Abraxane, lung cancer, Multinational biopharmaceutical company Celgene
Qiagen has won the US Food and Drug Administration (FDA) approval for its new molecular companion diagnostic product, therascreen KRAS RGQ PCR test kit, to provide guidance on the use of Erbitux for approximately 110,000 US patients with ...
Tags: Qiagen, FDA, molecular companion diagnostic product, test kit
Dako, a manufacturer of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest and Her2 Fish pharmDx kit as co diagnostics for pertuzumab (Perjeta), a Genentech cancer drug. ...
Tags: Dako, HER2-positive metastatic breast cance, HER2 FISH pharmDx Kit
NewLink Genetics HyperAcute-Pancreas Immunotherapy (algenpantucel-L) has gained European orphan designation. Orphan designation provides NewLink with access to multiple incentives for drug development in EU. Incentives include decreased ...
Tags: algenpantucel-L, NewLink Genetics, HyperAcute-Pancreas Immunotherapy
Diagnostic Biosystems (DBS) has launched the Mosaic 360 System with a product offering of novel Multiplex Immunohistochemistry kits and a complementary line of optimized IHC reagents. The company introduces a portfolio of five Mosaic ...
Agendia, a developer of genomic-based diagnostic products, has unveiled ColoPrint microarray-based 18-gene expression signature. The ColoPrint assay provides critical additional information for treatment decisions for stage II colon ...
Tags: ColoPrint, Agendia, colon cancer patients
Abbott will expand the current CE-IVD product labeling for its Vysis ALK Break Apart FISH Probe Kit to allow the test to be marketed in the European Union as a companion diagnostic. The test uses Abbott's proprietary fluorescence in situ ...
Tags: Abbott, anaplastic lymphoma kinase, ALK, FISH technology